The Clorox Company (CLX) — Fair Value Analysis

Base-case fair value (P50): $115.25 · Current price: $97.26 · Verdict: Undervalued

The Verdict on CLX

Based on our Monte Carlo simulations, Clorox (CLX) is currently considered Fairly Valued. While the current market price of $97.26 sits below our median fair value estimate of $115.25, the implied +18.5% is within a range typical for a defensive stock in this market. Our analysis suggests that the operational and financial health of CLX is average when compared to its peers within the Consumer Defensive sector, aligning with a valuation that acknowledges both its stability and inherent growth limitations. Investors should note this blend of moderate upside potential and an average quality tier.

How CLX stacks up against Consumer Defensive

CLX operates within the Consumer Defensive sector, a segment known for its resilience and consistent demand even during economic downturns. Our Monte Carlo simulations account for these sector-specific characteristics, modeling various forward scenarios for CLX. The $115.25 fair value reflects this stability, indicating a robust, albeit not explosive, growth outlook. While the current price of $97.26 offers an +18.5%, it's important to view this within the context of the sector's typically lower volatility. The average quality tier further suggests that CLX is a reliable player, but without standout operational advantages that would warrant a significantly higher premium or more aggressive upside forecast.

What this means for investors

For investors, the Fairly Valued verdict on CLX implies that the stock is trading at a reasonable price given its fundamentals and sector dynamics. The +18.5% from the current $97.26 to our $115.25 fair value offers a clear directional view. While there is potential for appreciation, investors seeking outsized gains might look elsewhere, or consider CLX primarily for its defensive qualities. Conversely, those concerned about downside risk can find comfort in its average quality tier and the stable nature of the Consumer Defensive sector. To explore the full distribution of potential outcomes, including bear and bull case scenarios, sign up for FairCurve to see the full distribution and track CLX's fair value as new fundamentals are released.

Frequently Asked Questions

Is CLX overvalued or undervalued right now?

Based on our Monte Carlo simulations, Clorox (CLX) is considered Fairly Valued. Our median fair value (P50) is $115.25 compared to the current price of $97.26.

What is the bear case and bull case for CLX?

The full Monte Carlo distribution, including specific price targets for bear (P10) and bull (P90) scenarios, along with the probability of upside, is available with a free FairCurve account.

How does FairCurve calculate CLX's fair value?

FairCurve calculates CLX's fair value using proprietary Monte Carlo simulations, modeling thousands of forward scenarios to generate a robust valuation distribution.

How can I track CLX's fair value as it changes?

Add CLX to a free FairCurve watchlist for daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released.